UBS Group AG

Holdings History for Aerovate Therapeutics, Inc. - COM (AVTE)

Symbol: AVTE on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	0%	$13.3K	6.34K	-4,708	-42.6%	$2.09	Q3 2024
6/30/2024	0%		$18.3K	11.1K	-185	-1.65%	$1.66	Q2 2024
3/31/2024	0%	0%	$332K	11.2K	-1,004	-8.2%	$29.57	Q1 2024
12/31/2023	0%	+0%	$277K	12.2K	+1,027	+9.16%	$22.63	Q4 2023
9/30/2023	0%	+0%	$152K	11.2K	+8,215	+274%	$13.57	Q3 2023
6/30/2023	0%	0%	$51.4K	3K	-2,987	-49.9%	$17.15	Q2 2023
3/31/2023	0%	+0%	$121K	5.99K	+5,986	NEW	$20.17	Q1 2023
12/31/2022		0%	$0	0	-1,612	-100%		Q4 2022
9/30/2022	0%	+0%	$26K	1.61K	+1,612	NEW	$16.13	Q3 2022
3/31/2022		0%	$0	0	-484	-100%		Q1 2022
12/31/2021	0%	0%	$6K	484	-607	-55.6%	$12.40	Q4 2021
9/30/2021	0%	0%	$23K	1.09K	-959	-46.8%	$21.08	Q3 2021
6/30/2021	0%	+0%	$47K	2.05K	+2,050	NEW	$22.93	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.